Viewing data from:

DROXIDOPA

ANDA

DROXIDOPA | A211741 | MSN PHARMACEUTICALS INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: NORTHERA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 6 NDCs

Highest NADAC/Unit

$2.71

per ea

Lowest NADAC/Unit

$0.4419

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
72205007490DROXIDOPA 300 MG CAPSULE	$2.71	EA	Generic	—	2026-06-17
00904739489DROXIDOPA 300 MG CAPSULE	$2.71	EA	Generic	—	2026-06-17
72205007390DROXIDOPA 200 MG CAPSULE	$1.13	EA	Generic	—	2026-06-17
00904739389DROXIDOPA 200 MG CAPSULE	$1.13	EA	Generic	—	2026-06-17
72205007290DROXIDOPA 100 MG CAPSULE	$0.4419	EA	Generic	—	2026-06-17
00904739289DROXIDOPA 100 MG CAPSULE	$0.4419	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$1552.22

Highest Price

$4722.22

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00904-7392-89DROXIDOPA 100MG CAP,ORAL	$1552.22	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-7393-89DROXIDOPA 200MG CAP,ORAL	$3000.00	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-7394-89DROXIDOPA 300MG CAP,ORAL	$4722.22	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain9 active DMFs1 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

MSN LIFE SCIENCES PRIVATE LTDDROXIDOPA

DMF 315142017

LUPIN MANUFACTURING SOLUTIONS LTDDROXIDOPA

DMF 320322017

DASAMI LAB PRIVATE LTDDROXIDOPA

DMF 321842017

QUIMICA SINTETICA SADROXIDOPA

DMF 322642017

MATRIX PHARMACORP PRIVATE LTDDROXIDOPA

DMF 330892018

CLAROCHEM IRELAND LTDDROXIDOPA

DMF 334592019

PIRAMAL PHARMA LTDDROXIDOPA

DMF 342582019

SUN PHARMACEUTICAL INDUSTRIES LTDDROXIDOPA

DMF 343892019

DASAMI LAB PRIVATE LTDDROXIDOPA (PROCESS-II)

DMF 353682020

SUMITOMO DAINIPPON PHARMA CO LTDInactiveDROXIDOPA

DMF 205562007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 100MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Feb 18, 2021

No patent or exclusivity listings for this strength.

#002 — 200MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 18, 2021

#003 — 300MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 18, 2021